SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) ...
Subdural hematoma with mild symptoms progressed significantly less often when treated with middle meningeal artery (MMA) embolization compared with observation alone, new results from the second phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results